Page last updated: 2024-11-05

tetraethylammonium and Hirschsprung Disease

tetraethylammonium has been researched along with Hirschsprung Disease in 1 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.

Research Excerpts

ExcerptRelevanceReference
"Hirschsprung's disease is the congenital absence of generating the peristaltic contractions transmitting from the proximal colon to rectum."1.37Tetraethylammonium enhances the rectal and colonic motility in rats and human in vitro. ( Dong, DL; Hu, CW; Jiang, HC; Li, Z; Liang, J; Ma, WC; Wu, JC; Xie, H; Xu, ZL; Yang, BF, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Z1
Xu, ZL1
Liang, J1
Wu, JC1
Hu, CW1
Xie, H1
Ma, WC1
Jiang, HC1
Yang, BF1
Dong, DL1

Other Studies

1 other study available for tetraethylammonium and Hirschsprung Disease

ArticleYear
Tetraethylammonium enhances the rectal and colonic motility in rats and human in vitro.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 384, Issue:2

    Topics: Animals; Child, Preschool; Colon; Gastrointestinal Motility; Hirschsprung Disease; Humans; Male; Mus

2011